NAD IV Therapy: Evidence, Safety, Side Effects, and Alternatives

NAD IV therapy delivers nicotinamide adenine dinucleotide directly into a vein, but human evidence is still early. NAD+ is important for energy metabolism and DNA repair, yet IV treatment has not been proven to extend human lifespan 1. Safety depends on sterile compounding, medical supervision, and patient screening.

What is NAD IV therapy?

NAD IV therapy means giving nicotinamide adenine dinucleotide through an IV line, usually in a clinic. The goal is to raise NAD-related activity in the body over a short visit, but that does not mean it has proven long-term health benefits.

What NAD+ does in the body

NAD+ is a form of vitamin B3 chemistry used by nearly every cell. It helps mitochondria turn food into ATP, the cell’s usable energy, and it also supports DNA repair, gene expression, cellular metabolism, and immune signaling 1.

NAD+ also works with enzymes such as sirtuins, PARP enzymes, and CD38. These systems are part of aging biology, but a pathway being linked to aging does not prove that an IV treatment extends human lifespan 1.

How IV NAD+ differs from NAD+ precursors like NR and NMN

NAD+ itself is the coenzyme. Nicotinamide riboside, or NR, and nicotinamide mononucleotide, or NMN, are precursors that cells can use to make NAD+. Human trials show that oral NR and NMN can raise NAD-related biomarkers, but biomarker changes are not the same as proven improvements in fatigue, cognition, disease risk, or lifespan 2, 3.

Why NAD+ is discussed in longevity research

NAD+ levels and NAD-dependent enzymes change with age in many models. That is why NAD+ is discussed in healthspan research. The careful way to say it is this: NAD biology is important, and NAD-targeted therapies are being studied, but human lifespan extension has not been proven for NAD IV therapy 1.

Does NAD IV therapy really work?

NAD IV therapy may change short-term NAD-related biology, but the human evidence is not strong enough to promise better energy, brain health, detox, recovery, or anti-aging results. The best current human IV data are limited, short-term, and not designed to prove broad wellness benefits.

What human clinical evidence can support

A 2026 retrospective review looked at commercial NAD+ IV and nicotinamide riboside IV use in humans. Participants received 500 mg NAD+ IV or NR IV over four consecutive days, with 30 days of follow-up; the study tracked symptoms, infusion time, vital signs, safety labs, and metabolic markers 4.

In that review, NAD+ IV infusions took longer on average than NR IV infusions, about 97 minutes versus 37 minutes. The same study reported no significant changes in several short-term safety markers, including ALT, AST, hsCRP, BUN/creatinine, and TSH during follow-up 4.

What remains unproven

The key limits are important. A retrospective record review can describe what happened in one setting, but it cannot prove that NAD IV therapy improves health outcomes. Larger prospective trials are needed before strong claims can be made about energy, cognition, metabolism, addiction recovery, or healthy aging 4.

Why biomarkers are not the same as outcomes

A biomarker is a measurement, such as a blood level, enzyme signal, or lab value. Biomarkers can help researchers understand a pathway, but patients usually care about outcomes: feeling better, functioning better, fewer events, or longer healthy life. For NAD+ therapies, that gap is still real 1, 4.

How to interpret anti-aging and energy claims

Be cautious when a claim jumps from cell or animal research to a guaranteed human benefit. Human randomized trials of oral NAD precursors have shown changes in NAD metabolites and some physiologic markers, but results vary by compound, dose studied, population, and outcome measured 2, 3, 5. Individual results vary.

What is NAD IV therapy used for?

NAD IV therapy is often marketed for wellness, fatigue, recovery, brain health, metabolism, and addiction support. These uses are better described as claims or research interests, not proven indications.

Wellness, fatigue, and recovery claims

The theory is that supporting NAD+ may support mitochondrial metabolism and ATP production. That theory is biologically plausible, but current IV research does not prove reliable improvements in fatigue or recovery for the general public 1, 4. Side effects such as nausea, cramping, chest pressure, and fatigue may also occur during or after infusion 4, 6.

Brain health and cognition research

NAD+ biology is relevant to neurons, mitochondrial function, inflammation, and vascular signaling. A registered clinical trial has evaluated NAD therapy for memory and brain blood flow, but a trial registration alone is not proof of benefit unless results are available and clinically meaningful 7.

Metabolic health research

NAD+ is central to cellular metabolism, so researchers have tested NAD precursors in metabolic health. In a randomized trial, NMN increased muscle insulin sensitivity in women with prediabetes, but that was not an NAD IV study and should not be used to promise IV results 3.

Addiction and withdrawal claims

Some clinics market NAD IV therapy for addiction or withdrawal support. For this use, the evidence remains limited, and it should not replace evidence-based addiction treatment, emergency care, or medication-assisted treatment when those are needed. Infusion-related adverse effects and sterile-product risks still apply 6.

What are the downsides and side effects of NAD IV therapy?

NAD IV therapy can be hard to tolerate for some people. The main downsides are infusion symptoms, uncertain long-term benefit, time, cost, and sterile-compounding risk.

Common infusion-related symptoms

In the 2026 commercial-setting review, people receiving NAD+ IV reported moderate to severe gastrointestinal symptoms, increased heart rate, and chest pressure during infusions; symptoms resolved after infusion completion 4. FDA has also received adverse event reports after NAD+ injectable drugs, including severe chills, shaking, vomiting, and fatigue, with some cases requiring medical treatment 6.

Why infusion speed may affect tolerability

The same review found NAD+ IV took longer than NR IV because symptoms were harder to tolerate. This suggests infusion speed and formulation may matter, but it does not create a safe do-it-yourself schedule; IV treatment should be supervised by trained clinicians 4.

Sterility, endotoxin, and contamination risks

Sterile compounding is a major safety issue because IV products go directly into the bloodstream. FDA has warned compounders not to use food-grade NAD+ sold by repackagers for sterile IV products because of microbial contamination and endotoxin risk 6.

Who should be cautious or seek clinician guidance first

People with heart rhythm symptoms, chest pain history, severe kidney or liver disease, pregnancy, complex medication lists, immune compromise, or prior infusion reactions should speak with a licensed clinician before considering any injectable NAD+ product. This is especially important because short-term studies cannot rule out rare or long-term risks 4, 6.

Is NAD IV therapy safe?

NAD IV therapy may be tolerated in some supervised settings, but “safe” is too broad without knowing the ingredient source, sterility testing, dose studied, infusion process, and patient health history. Short-term data do not answer long-term safety questions.

What short-term human observational data suggests

The 2026 retrospective review did not find significant short-term changes in several safety biomarkers after four days of NAD+ IV or NR IV, but it did find clear tolerability differences during infusions 4. That is useful, but observational data cannot prove safety for all patients.

What long-term safety data is missing

Long-term NAD IV safety data are limited. We do not yet have large, long-duration trials that track hard outcomes, rare adverse events, or repeated-use patterns across diverse patients 1, 4.

FDA warning on food-grade NAD+ used for sterile compounding

FDA’s warning is practical: ingredients meant for foods or supplements are not automatically suitable for sterile drugs. FDA specifically noted that food-grade NAD+ is not suitable for compounding sterile drugs without appropriate processing because microbes and endotoxins can harm patients 6.

Questions to ask any IV clinic before treatment

• Who reviews my health history before treatment: a licensed clinician or non-clinical staff?
• What ingredient grade is used, and is it suitable for sterile drug compounding?
• Which pharmacy prepares the sterile product, and is it state-licensed?
• What symptoms should stop an infusion, such as chest pressure, severe nausea, shaking, or shortness of breath?
• How are adverse events documented and followed after the visit?

How does NAD IV therapy compare with NAD+ injections, nasal spray, NR, and NMN?

NAD+ options differ by route, evidence, supervision, and tolerability. IV therapy is not the only route, and it is not automatically the best route just because it enters the bloodstream quickly.

Why route of administration matters

Route changes what must be monitored. IV and injection products require sterile preparation and carry different risks than oral supplements. Nasal spray avoids IV access but still needs clinician review when compounded and prescribed 6.

NAD+ at Chia: injections or nasal spray, not IV therapy

At Chia, NAD+ is available as compounded injection and nasal spray, not IV therapy; compounded medications are not FDA-approved. Plans for NAD+ currently start at $119/mo for nasal spray and $179/mo for injection, with current details on the NAD+ product page.

Here is how care works: you complete a short online health questionnaire, then one of our licensed US providers reviews your history. If NAD+ is clinically appropriate, the prescription is sent to a state-licensed US 503A compounding pharmacy and shipped to your door.

Dosing is provider-guided and adjusted over time. Patients can message the care team through the patient portal between visits. A clinician may decide NAD+ is not appropriate based on symptoms, medical history, medications, pregnancy status, or safety concerns.

NAD+ injection is also part of Chia’s Foundation Longevity protocol and Weight + Energy protocol. These protocols use compounded medications that are not FDA-approved, are not IV therapy, and are prescribed only when clinically appropriate.

Is NAD similar to Ozempic?

NAD+ is not similar to Ozempic in drug class or mechanism. Ozempic is semaglutide, a GLP-1 receptor agonist, while NAD+ is a coenzyme used in cellular metabolism.

Semaglutide works through GLP-1 receptor signaling, which affects glucose regulation, appetite pathways, and gastric emptying. Ozempic is FDA-approved for type 2 diabetes and certain cardiovascular and kidney risk-reduction uses described in its label; it is not an NAD+ product 8.

NAD+ should not be presented as a substitute for evidence-based obesity or diabetes medications. If your goal is weight care, metabolic care, or diabetes treatment, that calls for a clinician review and a plan matched to your diagnosis, labs, history, and medication risks.

How should patients evaluate NAD IV therapy claims?

NAD IV therapy claims should be judged by human outcomes, not only by cell biology or marketing language. A useful claim names the study type, the people studied, the route used, the outcome measured, and the side effects seen.

1. 1Look for human outcomes, not only cell or animal findings. Cell and animal studies can explain mechanisms, but they do not prove human healthspan or lifespan benefits.
2. 2Ask whether the product is compounded for sterile use. FDA has warned that food-grade NAD+ is not suitable for sterile injectable products without appropriate processing.
3. 3Ask who evaluates eligibility and monitors side effects. A licensed clinician should review your history before any injectable or IV treatment.
4. 4Be cautious with guaranteed anti-aging, detox, or energy claims. NAD+ biology is real, but broad outcome claims need stronger human evidence.
5. 5Ask what happens if symptoms occur. Chest pressure, severe nausea, shaking, vomiting, or shortness of breath should be taken seriously.

FAQ

Keep reading

Longevity

Nicotinamide Adenine Dinucleotide Injection: Uses, Evidence, Safety, and Cost

Longevity

NAD+ Injection vs Oral Supplements: What the Evidence Actually Shows

Longevity

NAD+ and Peptides: What They Are, How They Differ, and What They Do